Table II.
Clinical characteristics of the study population.
| Index | RA (n=10) | Control (n=10) | P-value |
|---|---|---|---|
| Sex (M/F) | 1:9 | 1:9 | 1 |
| Age (years) | 45.9±11.80 | 43.7±7.99 | 0.637 |
| ESR (mm/h) | 38±27.48 | NA | NA |
| Hs-CRP (mg/l) | 23.40±36.40 | NA | NA |
| RF (U/ml) | 109.48±82.34 | NA | NA |
| Anti-CCP (U/ml) | 164.75±226.34 | NA | NA |
| IgA (g/l) | 2.53±0.57 | NA | NA |
| IgG (g/l) | 13.88±3.40 | NA | NA |
| IgM (g/l) | 1.48±0.61 | NA | NA |
| C3 (g/l) | 1.23±0.27 | NA | NA |
| C4 (g/l) | 0.34±0.23 | NA | NA |
| DAS-28 score | 6.80±0.98 | NA | NA |
| VAS score | 6.95±0.94 | NA | NA |
| SAS score | 56.4±4.88 | NA | NA |
| SDS score | 56.6±6.07 | NA | NA |
| SF-36 score | 1302.1±14.99 | NA | NA |
Values are expressed as n or the mean ± standard deviation. NA, not available; M, male; F, female; RA, rheumatoid arthritis; C3, complement 3; anti-CCP, anti-cyclic citrullinated peptide antibody; hs-CRP, high-sensitivity C-reactive protein; DAS-28 score, 28-joint count rheumatoid arthritis disease activity score; ESR, erythrocyte sedimentation rate; NC, normal control; RA, rheumatoid arthritis; IgA, immunoglobulin A; lncRNA, long non-coding RNA; RT-PCR, reverse transcription-PCR; RF, rheumatoid factor; VAS, visual analogue scale; SAS, self-rating anxiety scale; SDS, self-rating depression scale; SF-36, 36-item short-form survey.